Efficacy of Paclitaxel plus TS1 against previously treated EGFR mutated non-small cell lung cancer

por Tseng, Yen-Han, Shih, Jen-Fu, Chao, Heng-Sheng, Chen, Yuh-Min
Publicado no PeerJ (2019)

Eight-Month Prospective Study of 14 Patients With Hospital-Acquired Severe Acute Respiratory Syndrome

por Chiang, Chi-Huei, Shih, Jen-Fu, Su, Wei-Juin, Perng, Reury-Perng
Publicado no Mayo Clin Proc (2004)

Erlotinib has better efficacy than gefitinib in adenocarcinoma patients without EGFR-activating mutations, but similar efficacy in patients with EGFR-activating mutations

por WU, WEN-SHUO, CHEN, YUH-MIN, TSAI, CHUN-MING, SHIH, JEN-FU, CHIU, CHAO-HUA, CHOU, KUN-TA, LAI, SHINN-LIANG, WU, CHIEH-HUNG, LUO, YUNG-HUNG, HUANG, CHU-YUN, LEE, YU-CHIN, PERNG, REURY-PERNG, WHANG-PENG, JACQUELINE
Publicado em 2012